These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2139 related articles for article (PubMed ID: 28187754)

  • 21. EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
    Pornsinchai P; Chongtrakool P; Diraphat P; Siripanichgon K; Malathum K
    Southeast Asian J Trop Med Public Health; 2015 Jan; 46(1):51-62. PubMed ID: 26513905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya.
    Abujnah AA; Zorgani A; Sabri MA; El-Mohammady H; Khalek RA; Ghenghesh KS
    Libyan J Med; 2015; 10(1):26412. PubMed ID: 25651907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI.
    Magale HI; Kassim IA; Odera SA; Omolo MJ; Jaoko WG; Jolly PE
    East Afr Med J; 2015 Jul; 92(7):333-337. PubMed ID: 27867208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing
    Mofolorunsho KC; Ocheni HO; Aminu RF; Omatola CA; Olowonibi OO
    Afr Health Sci; 2021 Jun; 21(2):505-512. PubMed ID: 34795702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
    Kader AA; Kumar A
    Ann Saudi Med; 2005; 25(3):239-42. PubMed ID: 16119526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period.
    Burgess DS; Hall RG; Lewis JS; Jorgensen JH; Patterson JE
    Pharmacotherapy; 2003 Oct; 23(10):1232-7. PubMed ID: 14594340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
    Bonkat G; Müller G; Braissant O; Frei R; Tschudin-Suter S; Rieken M; Wyler S; Gasser TC; Bachmann A; Widmer AF
    World J Urol; 2013 Dec; 31(6):1427-32. PubMed ID: 23358791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia].
    Blanco VM; Maya JJ; Correa A; Perenguez M; Muñoz JS; Motoa G; Pallares CJ; Rosso F; Matta L; Celis Y; Garzon M; Villegas MV
    Enferm Infecc Microbiol Clin; 2016 Nov; 34(9):559-565. PubMed ID: 26774256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
    Meier S; Weber R; Zbinden R; Ruef C; Hasse B
    Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.
    Søraas A; Sundsfjord A; Sandven I; Brunborg C; Jenum PA
    PLoS One; 2013; 8(7):e69581. PubMed ID: 23936052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
    Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and Laboratory Profile of Urinary Tract Infections Associated with Extended Spectrum β-Lactamase Producing Escherichia coli and Klebsiella pneumoniae.
    Al Yousef SA; Younis S; Farrag E; Moussa HSh; Bayoumi FS; Ali AM
    Ann Clin Lab Sci; 2016 Jul; 46(4):393-400. PubMed ID: 27466299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk factors, antimicrobial resistance patterns, and outcomes associated with extended-spectrum β-lactamases-Producing pathogens in pediatric urinary tract infection.
    He XT; Chang CN; Yu CH; Wang CC
    Pediatr Neonatol; 2024 May; 65(3):242-248. PubMed ID: 37951832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates.
    Ranjan Dash N; Albataineh MT; Alhourani N; Khoudeir AM; Ghanim M; Wasim M; Mahmoud I
    Travel Med Infect Dis; 2018; 22():46-50. PubMed ID: 29409967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colonization with selected antibiotic resistant bacteria among a cohort of Sri Lankan university students.
    Munasinghe T; Vidanapathirana G; Kuthubdeen S; Ekanayake A; Angulmaduwa S; De Silva K; Subhasinghe S; Kalupahana R; Liyanapathirana V; Ip M
    BMC Infect Dis; 2021 Jun; 21(1):578. PubMed ID: 34130629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil.
    Wollheim C; Guerra IM; Conte VD; Hoffman SP; Schreiner FJ; Delamare AP; Barth AL; Echeverrigaray S; Costa SO
    Braz J Infect Dis; 2011; 15(2):138-43. PubMed ID: 21503400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.
    Albaramki JH; Abdelghani T; Dalaeen A; Khdair Ahmad F; Alassaf A; Odeh R; Akl K
    Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.
    Jansåker F; Frimodt-Møller N; Sjögren I; Dahl Knudsen J
    J Antimicrob Chemother; 2014 Mar; 69(3):769-72. PubMed ID: 24107388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase
    Koksal E; Tulek N; Sonmezer MC; Temocin F; Bulut C; Hatipoglu C; Erdinc FS; Ertem G
    Investig Clin Urol; 2019 Jan; 60(1):46-53. PubMed ID: 30637361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 107.